LMS
0.61
229.7%
XPN
0.011
-26.7%
1MC
0.068
183.3%
SPX
0.003
-25%
AUH
0.002
100%
BGE
0.013
-23.5%
HAL
0.05
100%
G88
0.008
-20%
ADC
0.082
41.4%
OEL
0.004
-20%
C29
0.028
40%
ROG
0.004
-20%
TOE
0.45
38.5%
NC6
0.053
-18.5%
AR3
0.275
37.5%
RC1
0.009
-18.2%
BOC
1.3
36.8%
WLD
0.032
-17.9%
COB
0.15
36.4%
AM7
0.037
-17.8%
PSQ
2.18
36.3%
RDN
0.005
-16.7%
MIO
0.06
33.3%
PR2
0.155
-16.2%
TEG
0.004
33.3%
RBX
0.042
-16%
NVA
0.775
31.4%
SP8
0.011
-15.4%
MKR
0.076
31%
GG1
0.255
-15%
ASM
1.19
30.1%
TWE
5.93
-15%
CR1
0.155
27%
PRS
0.023
-14.8%
REE
0.038
26.7%
BNL
0.006
-14.3%
ARC
0.12
26.3%
IMI
0.012
-14.3%
5EA
0.925
25.9%
RAU
0.18
-14.3%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Imricor Medical Systems (ASX: IMR): Awarded CE mark approval

Developer of MRI-compatible devices, Imricor Medical Systems (ASX: IMR) has been awarded CE mark certification from the EU for its Vision-MR Diagnostic Catheter, allowing for manufacturing and release into the clinical market | ASX announcement: https://announcements.asx.com.au/asxpdf/20240306/pdf/0616gfxf12g8pc.pdf